no code implementations • 26 Jun 2019 • Ansh Kapil, Tobias Wiestler, Simon Lanzmich, Abraham Silva, Keith Steele, Marlon Rebelatto, Guenter Schmidt, Nicolas Brieu
The analysis of the tumor environment on digital histopathology slides is becoming key for the understanding of the immune response against cancer, supporting the development of novel immuno-therapies.
no code implementations • 28 Jun 2018 • Ansh Kapil, Armin Meier, Aleksandra Zuraw, Keith Steele, Marlon Rebelatto, Günter Schmidt, Nicolas Brieu
The level of PD-L1 expression in immunohistochemistry (IHC) assays is a key biomarker for the identification of Non-Small-Cell-Lung-Cancer (NSCLC) patients that may respond to anti PD-1/PD-L1 treatments.